At a glance
- Originator Bioprojet; Nonindustrial sources
- Class Imidazoles; Neuroprotectants; Nootropics; Oximes; Small molecules
- Mechanism of Action Histamine H3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 08 Mar 2001 Preclinical development for Cognition disorders in France (Unknown route)